Welcome to the February newsletter!
Rev. Rebecca Delzell
We have included a new interview feature. This month’s interview is one of a series of print interviews conducted by NCBAC™. The series includes leaders in the area of healthcare, aging and dementia. Some have conducted research, some are business leaders and others are experts in the best methods of day to day care.
Our next interview is with Rev. Rebecca Delzell, a hospice chaplain. Click here to read.
Our standard 3 articles and CEU quiz follow below.
How Chronic Loneliness Can Trigger Health Problems
Last time you visited your doctor, did he or she ask if you felt lonely? Did your doctor inquire about how many friendships you have or ask about how many community groups you are involved with?
There’s a growing body of research showing that extended loneliness and isolation are detrimental to health, and can even shorten people’s lives. One example is an analysis of about 70 studies conducted between 1980 and 2014 looking into loneliness and social isolation as risk factors for mortality.
What Caregivers Should Know About Managing a Loved One's Money
Age and ill health, particularly dementia or other conditions that affect memory and cognition, can impair a person's ability to responsibly manage one of the most important components of their livelihood: their money.
That makes it all the more important to have the uneasy but essential conversation with loved ones about who will oversee their finances, and how, if they no longer can. Here are some important legal and financial tools to understand and potential problems to look out for if you need to take on the role of money manager or find someone else who can.
The Next Frontier in Alzheimer’s Research
For all the bad news about Alzheimer's disease — the failed drug trials, the elusive target of amyloid plaques, the massive toll it's taking on our aging population and their caregivers — research into the brain disease has been given an unprecedented financial boost in recent years. Federal funding has soared to 2.4 billion dollars in 2019, as the National Institutes of Health has made this area of research a funding priority unmatched in scale since the agency's war on cancer in the 1970s.